Advertisement

Topics

Viventia Biotech Inc. Company Profile

12:44 EDT 20th September 2017 | BioPortfolio

Viventia Biotech Inc. is a leader in developing innovative therapeutics based upon the human immune response to cancer. Through its Hybridomics™ discovery platform and ImmunoMine™ screening technology, the Company is focused on developing "Totally Human" monoclonal antibodies either as targeted therapeutics, Armed Antibodies™, or as direct treatments to fight multiple forms of cancer.

Location

147 Hamelin Street
Winnipeg
Manitoba
R3T 3Z1
Canada

Contact

Phone: 204 478 1023
Fax: 204 452 7721
Email: hr@viventia.com


News Articles [3193 Associated News Articles listed on BioPortfolio]

3 Biotech Stocks to Buy If You've Never Bought a Biotech Stock

If you don't have biotech stocks in your investing portfolio, why not? For many people, the answer is that they think biotech stocks are too risky. Although it's true that some biotech stocks ...

#news #biotech German biotech on the rise

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: German biotech on the rise . from European Biotechnology – first and fo...

The 15 Best Biotech Incubators in Europe, Hatching Future Biotech Stars

Get to know 15 of the best biotech incubator across Europe where some of the best companies moving billions of euros get started. The best ideas in biotech need a catalyst to turn ideas into reality. ...

The 7 Best Biotech Companies in Europe’s History

We’ve put together a list of the best biotech companies in Europe to celebrate their invaluable contributions to science and the development of the booming industry biotech is today.  Though th...

UK biotech is catching up to the US, but will it run out of gas?

The UK is far ahead of its European biotech rivals according to a new report, but will it fulfill its promise of becoming a global hub? According to analysis by the BioIndustry Association, the UK is...

Japan, A Potential Biotech Sugar Beet Country

Japan has the potential to adopt biotech crops in the future with the increasing importation of biotech maize, soybean, canola, and cotton, which in 2016 was recorded at 20.9 million metric tons. Abou...

BB Biotech: Rückenwind für Investoren von Biotech-Aktien

Küsnacht - Im 2. Quartal erzielte die BB Biotech-Aktie eine Gesamtrendite von 4.2% in CHF, 1.6% in EUR und 9.0% in USD. Der Innere Wert (NAV) stieg um 3.2% in CHF, woraus ein Quartalsgewinn von CH...

Infographic: Global Status of Commercialized Biotech/GM Crops in 2016

ISAAA summarized the highlights of Global Status of Commercialized Biotech/GM Crops: 2016 into a one-page infographic. It includes visual figures on the global area of biotech crops, percentage of dev...

Drugs and Medications [8 Associated Drugs and Medications listed on BioPortfolio]

Ocufresh [Taiwan Biotech Co, Ltd]

Minidrops [Taiwan Biotech Co, Ltd]

Iman time control all day moisture complex spf 15 [Sheencolor Biotech Co., Ltd.]

Drug Fact

Iman time control oil free moisture complex spf 15 [Sheencolor Biotech Co., Ltd.]

Drug Fact

Stelara [Janssen Biotech, Inc.]

These highlights do not include all the information needed to use STELARA safely and effectively. See full prescribing information for STELARA. STELARA (ustekinumab) Injection, for subcutaneous useIn...

Clinical Trials [12 Associated Clinical Trials listed on BioPortfolio]

A Phase 3 Clinical Trial for a Rabies Vaccine (Vero Cell) for Human Use in Healthy Chinese Subjects

The purpose of this single-centre, randomized, double-blind, parallel control, phase 3 study is to evaluate the safety and immunogenicity of a rabies vaccine (Vero Cell) for human use in h...

Phase I Hepatitis C Vaccine Trial of Virosome-formulated Peptides

Pevion Biotech has designed a therapeutic vaccine to treat patients who suffer from chronic hepatitis C virus infection. The vaccine is based on a combination of the PeviPRO and PeviTER pl...

Five-year Immune Persistence Study of Inactivated Enterovirus Type 71 (EV71) Vaccine

The purpose of this study is to evaluate the 5-year Immune Persistence of Inactivated Enterovirus Type 71 (EV71) Vaccine manufactured by Sinovac (Beijing) Biotech Co., Ltd.

Non-steroid, Atopic Dermatitis Phase IIb 12-week Trial; Topical WBI-1001 Cream

Welichem Biotech has developed a small molecule drug candidate, WBI-1001, that selectively targets the pathogenic features of inflammatory skin diseases, including atopic dermatitis (a for...

Bioequivalence Study of Mycophenolate Mofetil 250 mg Capsule Under Fed Condition

The objective of the study is to compare the bioavailability and characterise the pharmacokinetic profile of Mycophenolate mofetil 250 mg capsules Panacea Biotech Ltd, India and Cellcept®...

Companies [871 Associated Companies listed on BioPortfolio]

Viventia Biotech Inc

Viventia Biotech Inc. is a biopharmaceutical company advancing a new generation of monoclonal antibody therapeutics designed to offer safer, more beneficial therapies for cancer patients. Viventia’s...

Viventia Biotech Inc.

Viventia Biotech Inc. is a leader in developing innovative therapeutics based upon the human immune response to cancer. Through its Hybridomics™ discovery platform and ImmunoMine™ screening techno...

BioTech Umeå

The Biotech industry stimulates growth and creates new job opportunities in Sweden. The city of Umeå hosts first-rate biotech research. BioTech Umeå is a driving force helping the industry as well a...

Rhein Biotech N.V.

Rhein Biotech is a globally active biotech company and the world's third largest hepatitis B vaccine manufacturer. Berna Biotech, a fully integrated vaccine focused biotechnology company acquired 92.2...

M-Biotech, Inc.

M-Biotech was founded in 1997 and is located in Salt Lake City, Utah. M-Biotech's core business includes the research and development of biosensors for health care applications. Based on M-Biotech's p...

More Information about "Viventia Biotech Inc." on BioPortfolio

We have published hundreds of Viventia Biotech Inc. news stories on BioPortfolio along with dozens of Viventia Biotech Inc. Clinical Trials and PubMed Articles about Viventia Biotech Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Viventia Biotech Inc. Companies in our database. You can also find out about relevant Viventia Biotech Inc. Drugs and Medications on this site too.

Quick Search
Advertisement
 

Relevant Topics

Biotechnology - Biotech
"using living things to create products or to do tasks for humans" About Biotechnology - Biotech Biotechnology is the practice of using plants, animals and micro-organisms such as bacteria, as well as biological processes - such as the ripen...

Head and neck cancers
Cancer can occur in any of the tissues or organs in the head and neck. There are over 30 different places that cancer can develop in the head and neck area. Mouth cancers (oral cancers)  - Mouth cancer can develop on the lip, the tongue, the floor...

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...


Corporate Database Quicklinks



Searches Linking to this Company Record